“drug-development” Archives

in
Entry Author Date Location
CymaBay PBC Drug Hits Phase 3 Goals With Signs of Side Effect Advantage 08/04/20 San Francisco
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs 07/21/20 New York
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs 06/25/20 Boston
Viela Bio Gets FDA Green Light for Rare Autoimmune Disease Treatment 06/12/20 National
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Sarepta Eyes Key Test for Gene Therapy in Rare Muscular Dystrophy 06/08/20 Boston
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Deciphera Pharmaceuticals Wins Early FDA Nod for GI Cancer Treatment 05/15/20 Boston
Trovagene Rebrands as Cardiff Oncology, Promotes Longtime Exec to CEO 05/07/20 San Diego
PTC Therapeutics to Acquire Censa Pharma for Mid-Stage Rare Disease Drug 05/07/20 New York
Kura Narrows Pipeline After Strategic Review Prompted by COVID-19 05/05/20 San Diego
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill 04/27/20 San Diego
Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic 04/27/20 San Diego
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies 04/24/20 San Francisco
Biogen Pushes Finalized Filing for Alzheimer’s Drug to Third Quarter 04/22/20 Boston
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Unlearn Adds $12M for “Digital Twins” That Accelerate Clinical Trials 04/20/20 San Francisco
Seattle Genetics Gets Early FDA Nod for Breast Cancer Combo Drug 04/18/20 Seattle
Cerevance Raises $45M to Advance Brain Disease Research & Development 04/14/20 Boston
Millendo May Restructure After Prader-Willi Drug Fails Pivotal Test 04/06/20 Detroit Ann Arbor
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
Sanofi Wins FDA Nod for Combo Therapy in Multiple Myeloma 03/03/20 National
Page 1 of 19 next page »